Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Walgreens Terminates Partnership With Blood Test Company, Theranos

XTALKS VITALS NEWS

Blood Test

The tests – which require just a single drop of blood – have already stopped being sold in California.

Share this!

June 14, 2016 | by Sarah Massey, M.Sc.

Tweet: Walgreens ends partnership with #Theranos. http://ctt.ec/C4nBX+

Walgreens has officially ended its partnership with medical laboratories services company, Theranos. The US pharmacy giant is set to close all 40 of the Theranos blood testing centers in its Arizona drugstores.

These locations were the last ones still operating after questions were raised regarding the accuracy of Theranos’ blood test results. The tests – which require just a single drop of blood – have already stopped being sold in California.

Loss of the Walgreens partnership is just the most recent blow to the California-based blood test company. While Theranos does operate its own retail testing centers, the Walgreens locations in Arizona were believed to bring in the majority of its customers.

The Centers for Medicare and Medicaid Services (CMS) are considering banning Theranos founder Elizabeth Holmes from operating a blood testing facility for two years, after federal regulators identified a number of issues at its lab in Newark, California. Theranos is also facing an ongoing Securities and Exchange Commission (SEC) investigation.



“In light of the voiding of a number of test results, and as the Centers for Medicare and Medicaid Services has rejected Theranos’s plan of correction and considers sanctions, we have carefully considered our relationship with Theranos and believe it is in our customers’ best interests to terminate our partnership,” said senior vice president of Walgreens, Brad Fluegel.

Formerly hailed as a Silicon Valley darling, Theranos offered fingerprick blood tests which the company claimed would be more accurate and less expensive than traditional tests. Despite voiding the results of tens of thousands of blood tests, the company has so far only corrected less than one percent of the affected results.

“We are disappointed that Walgreens has chosen to terminate our relationship and remain fully committed to our mission to provide patients access to affordable health information,” said a statement released by Theranos. “Quality and safety are our top priorities and we are working closely with government officials to ensure that we not only comply with all federal regulations but exceed them.”


Keywords: Blood Test, Theranos, Pharmacy


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Lavazza Acquires Controlling Stake in Canada’s Kicking Horse Coffee

May 26, 2017 - Italian coffee company Lavazza, has secured an 80 percent equity stake in Canadian organic and fair-trade coffee company Kicking Horse Coffee, in a deal worth CAD$215 million.

Featured In: Food News


FDA First: Keytruda Approved for Cancer Treatment Based on Biomarker Alone

May 25, 2017 - For the first time, the FDA has approved a cancer treatment for solid tumors based on the presence of a biomarker, as opposed to specifying a tissue of origin.

Featured In: Biotech News


One Year of Medically Assisted Dying in Canada

May 25, 2017 - In June of 2016, the federal government of Canada passed legislation to legalize medically assisted dying.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Top 5 Most Impactful Tweets in Life Sciences During the Last Week

REGISTER FOR THESE WEBINARS

EU IVD Regulation: Top Five Changes for Medical Device Manufacturers to Consider


Thermal Processing Systems for the Food Industry: A Guide to Selecting Thermal Equipment and Technology


Rare Disease & Orphan Drug Development: Cost-Efficient Trial Design to Minimize Cash Burn


eTMF Workflows: Active eTMF to Improve the Quality of Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.